16 July 2021>: Original PaperAnke Schwarz 1ADEF** , Frank Schäfer 1AB* , Theodor Framke 2CD , Silvia Linnenweber-Held 1AB , Nicolas Richter 3BD , Hermann Haller 1DE
Ann Transplant 2021; 26:e928922
Figure 4 Cardiovascular disease(A) Graft as well as patient survival of 65 TX1 patients with compared to 97 TX1 patients without cardiovascular disease were significantly inferior (p=0.0177 and p=0. 0028, respectively). (B) Graft as well as patient survival in 61 TX2 patients with compared to 101 TX2 patients without cardiovascular disease were significantly inferior. However, in TX2 patients this relationship was more robust than in TX1 patients (p=0.0006 and p=p<0.0001, respectively).